Clinical Trial Update: Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updates the efficacy of intravenous Amboxol hydrochloride as an adjunct therapy for severe pneumonia in critically ill patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Critical Illness
• Hospital-acquired Pneumonia
• Pneumonia

Drugs mentioned

• Amboxol hydrochloride (Amboxol hydrochloride)

Snippet

Sponsor: National University of Malaysia | Conditions: Severe Pneumonia, Community-acquired Pneumonia | Phase 4 | Status: COMPLETED